NEW YORK, May 16, 2019 /PRNewswire/ -- A new study on the usage patterns of pediatric hexavalent vaccines reveals that Sanofi's vaccine "Hexaxim" was the most administered hexavalent vaccine in the world in 2018 with 63% of volume share, followed by Infanrix Hexa (33%,) and Vaxelis 4%.
Hexavalent vaccines are six in-one combination vaccines that protect babies against diphtheria, tetanus, pertussis (whooping cough), poliomyelitis, haemophilus influenza type B and hepatitis B.
Also, most public markets occur in high and upper middle-income countries and most private markets in lower middle- and low-income countries.
To read the summary and download the full report click here.
Feel free to contact me for more information or for an interview with the analysts in charge of this report.
Media Contact:Intissar Guettouigu@reportlinker.comT: +1 347 903 1913
About Reportlinker Insight: Reportlinker Insight combines analysis and exclusive investigations. We cover innovations, social and economics megatrends to understand the world of tomorrow. For more information, please visit http://www.reportlinker.com/insight/.
View original content:http://www.prnewswire.com/news-releases/sanofis-pediatric-vaccine-hexaxim-is-the-most-administered-hexavalent-vaccine-in-the-world-with-63-of-volume-share-300852031.html
Subscribe to our Free Newsletters!